🎁 Black Friday: up to 50% off of annual plans
MedPacto, Inc. (KOSDAQ:235980)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,655.00
-100.00 (-2.66%)
Nov 20, 2026, 3:30 PM KST

MedPacto Revenue

MedPacto had revenue of 1.00B KRW in the quarter ending September 30, 2026, a decrease of -16.31%. This brings the company's total for the last twelve months to 4.80B, up 94.37% year-over-year. In the year 2025, MedPacto had annual revenue of 3.90B. That makes MedPacto the 41,044th largest company in the world by revenue and 2,527th in South Korea.

Revenue (ttm)
4.80B
Revenue Growth
+94.37%
P/S Ratio
26.10
Revenue / Employee
85.70M
Employees
56
Market Cap
125.28B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.90B--
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Bioneer345.88B
GC Cell162.00B
HLB Therapeutics64.45B
GC Genome32.64B
Anterogen.Co.,Ltd.9.29B
NeoImmuneTech6.60B
Genexine5.81B
iNtRON Biotechnology5.74B
Revenue Rankings